European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer

Stanel, SC; Sjoberg, J; Salmonson, T; Foggi, P; Caleno, M; Melchiorri, D; Gravanis, I; Tzogani, K; Pignatti, F

Tzogani, K (reprint author), European Medicines Agcy, London, England.

ESMO OPEN, 2017; 2 (2):

Abstract

On 1 February 2013, a marketing authorisation valid throughout the European Union was issued for aflibercept (Zaltrap) in combination with irinotecan/......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索